ArticleFrontiers in surgery2026
Circumferential laryngopharyngectomy with free jejunal transfer for hypopharyngeal cancer: a retrospective cohort analysis of outcomes and complications.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Hypopharyngeal squamous cell carcinoma (HSCC) is often diagnosed at an advanced stage and characterized by poor prognosis. While primary (chemo)radiotherapy is frequently preferred for early and intermediate stage disease, total laryngopharyngectomy (TLP) remains the gold standard for the primary treatment of locally advanced tumors and for salvage treatment of residual and recurrent HSCC. However, reconstruction of a circumferential hypopharyngeal defect is challenging. This retrospective cohort analysis evaluates the oncological and functional outcomes of TLP with free jejunal transfer (FJT). Methods: 22 patients with histopathologically confirmed HSCC requiring TLP with FJT were included. Data on patient demographics, tumor characteristics, and functional and oncological outcomes were analyzed with overall survival (OS) as primary outcome. Results: Overall, 22 patients were included (18.2% female, mean age 65.6 years). Mean follow-up time was 3.9 years. Primary and salvage TLP was performed in 8 (36.4%) and 14 (63.6%) patients respectively. All primary tumors were stage IV. In the salvage group, patients had disease stage II ( Conclusion: FJT deserves its place in the reconstructive armamentarium following TLP. Oncological outcomes are good and functional outcomes are acceptable but there is room for improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.